Neural bases for addictive properties of benzodiazepines

Nature

Volumn 463, Issue 7282, 2010, Pages 769-774

  Tan, Kelly R ^a   Brown, Matthew ^a   Labouébe, Gwenaël ^a   Yvon, Cédric ^a   Creton, Cyril ^a   Fritschy, Jean Marc ^b   Rudolph, Uwe ^c   Lüscher, Christian ^a,d,e  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c MCLEAN HOSPITAL   (United States)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e Geneva Neuroscience Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; FLUMAZENIL; MIDAZOLAM; ZOLPIDEM;

BIOCHEMISTRY; CYTOLOGY; DRUG; DRUG USER; NEUROLOGY; PATHOLOGY;

ARTICLE; DOPAMINERGIC NERVE CELL; INTERNEURON; NERVE CELL PLASTICITY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

ACTION POTENTIALS; ADMINISTRATION, ORAL; ANIMALS; BEHAVIOR, ADDICTIVE; BENZODIAZEPINES; DOPAMINE; ELECTRIC CONDUCTIVITY; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; MICE; MICE, INBRED C57BL; MIDAZOLAM; MODELS, BIOLOGICAL; MORPHINE; NEURONAL PLASTICITY; NEURONS; ORGAN SPECIFICITY; RECEPTORS, AMPA; RECEPTORS, GABA-A; SUBSTRATE SPECIFICITY; VENTRAL TEGMENTAL AREA;

EID: 76749109881     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08758     Document Type: Article

References (48)

1. Lüscher, C. & Ungless, M. A. The mechanistic classification of addictive drugs. PLoS Med. 3, e437 (2006).
2. O'Brien, C. P. Benzodiazepine use, abuse, and dependence. J. Clin. Psychiatry 66 (suppl. 2), 28-33 (2005).
3. Saal, D., Dong, Y., Bonci, A. & Malenka, R. C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37, 577-582 (2003).
4. Bellone, C. & Lüscher, C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nature Neurosci. 9, 636-641 (2006).
5. Argilli, E., Sibley, D. R., Malenka, R. C., England, P. M. & Bonci, A. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 28, 9092-9100 (2008).
6. Mameli, M., Balland, B., Lujan, R. & Luscher, C. Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 317, 530-533 (2007).
7. Heikkinen, A. E., Moykkynen, T. P. & Korpi, E. R. Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacol. 34, 290-298 (2009).
8. Johnson, S. W. & North, R. A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. (Lond.) 450, 455-468 (1992).
9. A receptors: relative orientation of ligands and amino acid side chains. Mol. Pharmacol. 54, 1097-1105 (1998).
10. Fritschy, J. M. & Mohler, H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154-194 (1995).
11. Okada, H., Matsushita, N., Kobayashi, K. & Kobayashi, K. Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons. J. Neurochem. 89, 7-14 (2004).
12. Arendt, R. M., Greenblatt, D. J., Liebisch, D. C., Luu, M. D. & Paul, S. M. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology (Berl.) 93, 72-76 (1987).
13. A receptor subtypes. Nature 401, 796-800 (1999).
14. Möhler, H., Benke, D., Mertens, S. & Fritschy, J. M. GABAA-receptor subtypes differing in a-subunit composition display unique pharmacological properties. Adv. Biochem. Psychopharmacol. 47, 41-53 (1992).
15. A receptor alpha1 subtype. Nature Neurosci. 3, 587-592 (2000).
16. Cameron, D. L., Wessendorf, M. W. & Williams, J. T. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77, 155-166 (1997).
17. Margolis, E. B., Lock, H., Hjelmstad, G. O. & Fields, H. L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J. Physiol. (Lond.) 577, 907-924 (2006).
18. Hsia, A. Y., Malenka, R. C. & Nicoll, R. A. Development of excitatory circuitry in the hippocampus. J. Neurophysiol. 79, 2013-2024 (1998).
19. A receptor function by benzodiazepines in area CA3 of rat hippocampal slice cultures. Neuropharmacology 35, 1169-1179 (1996).
20. 21 influx and glutamate release. J. Biol. Chem. 284, 8726-8737 (2009).
21. A receptor-channel kinetic behavior. Eur. J. Neurosci. 25, 2726-2740 (2007).
22. A receptors to a dopamine hyperfunction. Proc. Natl Acad. Sci. USA 102, 17154-17159 (2005).
23. Löw, K., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131-134 (2000).
24. Robinson, S., Smith, D. M., Mizumori, S. J. & Palmiter, R. D. Firing properties of dopamine neurons in freely moving dopamine-deficient mice: effects of dopamine receptor activation and anesthesia. Proc. Natl Acad. Sci. USA 101, 13329-13334 (2004).
25. Hyland, B. I., Reynolds, J. N., Hay, J., Perk, C. G. & Miller, R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475-492 (2002).
26. Pilotto, R., Singer, G. & Overstreet, D. Self-injection of diazepam in naive rats: effects of dose, schedule and blockade of different receptors. Psychopharmacology (Berl.) 84, 174-177 (1984).
27. Fuchs, V., Burbes, E. & Coper, H. The influence of haloperidol and aminooxyacetic acid on etonitazene, alcohol, diazepam and barbital consumption. Drug Alcohol Depend. 14, 179-186 (1984).
28. Berridge, K. C. & Pecina, S. Benzodiazepines, appetite, and taste palatability. Neurosci. Biobehav. Rev. 19, 121-131 (1995).
29. Yerbury, R. E. & Cooper, S. J. Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23-0364, in the rat. Pharmacol. Biochem. Behav. 33, 303-307 (1989).
30. A receptor modulation is not necessary for benzodiazepine-induced hyperphagia. Appetite 52, 675-683 (2009).
31. Kalivas, P. W., Duffy, P. & Eberhardt, H. Modulation of A10 dopamine neurons by c-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 253, 858-866 (1990).
32. A receptors-an in vivo electrochemical study. Brain Res. 798, 156-165 (1998).
33. B receptors in the regulation of the nucleus accumbens dopamine response to stress. Brain Res. 1150, 62-68 (2007).
34. Grace, A. A. & Bunney, B. S. Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol. 59, 211-218 (1979).
35. Klitenick, M. A., DeWitte, P. & Kalivas, P. W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12, 2623-2632 (1992).
36. Soyka, M., Bottlender, R. & Moller, H. J. Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 33, 138-141 (2000).
37. Rowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R. & Dawson, G. R. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc. Natl Acad. Sci. USA 102, 915-920 (2005).
38. A receptor subtype functions. Curr. Opin. Pharmacol. 6, 18-23 (2005).
39. Koob, G. F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 42 (suppl. 1), S32-S41 (2009).
40. Lüscher, C. & Bellone, C. Cocaine-evoked synaptic plasticity: a key to addiction? Nature Neurosci. 11, 737-738 (2008).
41. Mameli, M., et al. Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nature Neurosci. 12, 1036-1041 (2009).
42. Redish, A. D., Jensen, S. & Johnson, A. A unified framework for addiction: vulnerabilities in the decision process. Behav. Brain Sci. 31, 415-437 (2008).
43. B receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nature Neurosci. 10, 1559-1568 (2007).
44. Zhao, S., et al. Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci. 19, 1133-1140 (2004).
45. Tamamaki, N., et al. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J. Comp. Neurol. 467, 60-79 (2003).
46. Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates (Elsevier, 2004).
47. Grace, A. A. & Bunney, B. S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10, 301-315 (1983).
48. Ungless, M. A., Magill, P. J. & Bolam, J. P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303, 2040-2042 (2004).